Detail akcie Amneal Phrmctl Rg-A online

Business Summary: Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Amneal Pharmaceuticals Inc revenues increased 7% to $2.2B. Net income totaled $37M vs. loss of $85.8M. Revenues reflect Affordable Medicines segment increase of 5% to $1.31B, AvKARE segment increase of 8% to $534M, Speciality segment increase of 11% to $361.6M. Net Income reflects Affordable Medicines segment income increase of 68% to $298.8M, AvKARE segment income increase of 64% to $58.1M.